Pacira BioSciences, Inc. (PCRX) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pacira Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.737 Good day, and thank you for standing by. Welcome to the Becerra Biosciences Q2 2025 00:00:05.737 -- 00:00:11.584 earnings conference call. At this time, all participants are in listen-only mode. 00:00:11.584 -- 00:00:15.488 After the speaker's presentation, there will be a question and answer session. 00:00:15.488 -- 00:00:20.614 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:20.614 -- 00:00:24.799 You will then hear an automated message advising your hand is raised. 00:00:24.799 -- 00:00:28.297 To withdraw your question, please press star 1 1 again. 00:00:28.297 -- 00:00:31.762 Please be advised that today's conference is being recorded. 00:00:31.762 -- 00:00:36.229 I would now like to hand the conference over to your first speaker today, Susan Mesko, 00:00:36.229 -- 00:00:39.033 Head of Investor Relations. Please go ahead. 00:00:39.033 -- 00:00:41.033 Thank 00:00:42.277 -- 00:00:46.884 you. Good afternoon, everyone. Welcome to today's conference call to discuss our second 00:00:46.884 -- 00:00:52.112 quarter 2025 financial results. Joining me are Frank Lee, Chief Executive 00:00:52.112 -- 00:00:57.259 Officer, Brendan Tehan, Chief Commercial Officer, and Sean Cross, Chief Financial 00:00:57.259 -- 00:01:02.386 Officer. Tony Molloy, Chief Legal and Compliance Officer, is also here for today's 00:01:02.386 -- 00:01:07.211 question and answer session. Before we begin, let me remind you that this call will include 00:01:07.211 -- 00:01:12.316 forward-looking statements subject to the State Harbor provisions of federal securities 00:01:12.316 -- 00:01:17.901 laws. Such statements represent our judgment as of today and may involve risks 00:01:17.901 -- 00:01:23.126 and uncertainties. This...